Target ID |
Target Type |
Target Name |
Target Organism |
Activity Type |
Activity Relation |
Value |
Unit |
Reference |
NPT2589 |
Cell Line |
Panel leukemia (Carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
100.0 |
nM |
PMID[12036377] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
GI50 |
= |
251.19 |
nM |
PMID[12036377] |
NPT2589 |
Cell Line |
Panel leukemia (Carcinoma cell lines) |
Homo sapiens |
TGI |
= |
-4.8 |
n.a. |
PMID[12036377] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
TGI |
= |
-4.8 |
n.a. |
PMID[12036377] |
NPT2589 |
Cell Line |
Panel leukemia (Carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
-3.2 |
n.a. |
PMID[12036377] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
LC50 |
= |
-3.6 |
n.a. |
PMID[12036377] |
NPT4720 |
Cell Line |
Leukemia cells |
Homo sapiens |
GI50 |
= |
7.0 |
n.a. |
PMID[16107161] |
NPT517 |
Cell Line |
Panel NCI-60 (60 carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
6.7 |
n.a. |
PMID[16107161] |
NPT4720 |
Cell Line |
Leukemia cells |
Homo sapiens |
TGI |
= |
4.8 |
n.a. |
PMID[16107161] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
TGI |
= |
4.8 |
n.a. |
PMID[16107161] |
NPT6511 |
Cell Line |
Colon cells |
Homo sapiens |
TGI |
= |
5.4 |
n.a. |
PMID[16107161] |
NPT5530 |
Cell Line |
CNS cells |
Homo sapiens |
TGI |
= |
5.2 |
n.a. |
PMID[16107161] |
NPT3880 |
Cell Line |
Melanoma cells |
Homo sapiens |
TGI |
= |
5.1 |
n.a. |
PMID[16107161] |
NPT6428 |
Cell Line |
Ovarian carcinoma cells |
Homo sapiens |
TGI |
= |
4.7 |
n.a. |
PMID[16107161] |
NPT6593 |
Cell Line |
Renal cells |
Homo sapiens |
TGI |
= |
4.7 |
n.a. |
PMID[16107161] |
NPT6369 |
Cell Line |
Prostate cells |
Homo sapiens |
TGI |
= |
5.2 |
n.a. |
PMID[16107161] |
NPT5230 |
Cell Line |
Breast carcinoma cells |
Homo sapiens |
TGI |
= |
5.1 |
n.a. |
PMID[16107161] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
GI50 |
= |
6.6 |
n.a. |
PMID[16107161] |
NPT517 |
Cell Line |
Panel NCI-60 (60 carcinoma cell lines) |
Homo sapiens |
TGI |
= |
5.0 |
n.a. |
PMID[16107161] |
NPT4720 |
Cell Line |
Leukemia cells |
Homo sapiens |
LC50 |
= |
3.2 |
n.a. |
PMID[16107161] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
LC50 |
= |
3.6 |
n.a. |
PMID[16107161] |
NPT6511 |
Cell Line |
Colon cells |
Homo sapiens |
LC50 |
= |
4.1 |
n.a. |
PMID[16107161] |
NPT5530 |
Cell Line |
CNS cells |
Homo sapiens |
LC50 |
= |
3.7 |
n.a. |
PMID[16107161] |
NPT3880 |
Cell Line |
Melanoma cells |
Homo sapiens |
LC50 |
= |
3.6 |
n.a. |
PMID[16107161] |
NPT6428 |
Cell Line |
Ovarian carcinoma cells |
Homo sapiens |
LC50 |
= |
3.5 |
n.a. |
PMID[16107161] |
NPT6593 |
Cell Line |
Renal cells |
Homo sapiens |
LC50 |
= |
3.6 |
n.a. |
PMID[16107161] |
NPT6369 |
Cell Line |
Prostate cells |
Homo sapiens |
LC50 |
= |
3.5 |
n.a. |
PMID[16107161] |
NPT5230 |
Cell Line |
Breast carcinoma cells |
Homo sapiens |
LC50 |
= |
3.5 |
n.a. |
PMID[16107161] |
NPT6511 |
Cell Line |
Colon cells |
Homo sapiens |
GI50 |
= |
7.0 |
n.a. |
PMID[16107161] |
NPT517 |
Cell Line |
Panel NCI-60 (60 carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
3.6 |
n.a. |
PMID[16107161] |
NPT5530 |
Cell Line |
CNS cells |
Homo sapiens |
GI50 |
= |
6.9 |
n.a. |
PMID[16107161] |
NPT3880 |
Cell Line |
Melanoma cells |
Homo sapiens |
GI50 |
= |
6.8 |
n.a. |
PMID[16107161] |
NPT6428 |
Cell Line |
Ovarian carcinoma cells |
Homo sapiens |
GI50 |
= |
6.5 |
n.a. |
PMID[16107161] |
NPT6593 |
Cell Line |
Renal cells |
Homo sapiens |
GI50 |
= |
6.5 |
n.a. |
PMID[16107161] |
NPT6369 |
Cell Line |
Prostate cells |
Homo sapiens |
GI50 |
= |
6.9 |
n.a. |
PMID[16107161] |
NPT5230 |
Cell Line |
Breast carcinoma cells |
Homo sapiens |
GI50 |
= |
6.5 |
n.a. |
PMID[16107161] |
NPT377 |
Cell Line |
OVCAR-3 |
Homo sapiens |
IC50 |
= |
10.0 |
nM |
PMID[15857148] |
NPT458 |
Cell Line |
IGROV-1 |
Homo sapiens |
IC50 |
= |
10.0 |
nM |
PMID[15857148] |
NPT83 |
Cell Line |
MCF7 |
Homo sapiens |
IC50 |
= |
10.0 |
nM |
PMID[15857148] |
NPT2318 |
Cell Line |
A172 |
Homo sapiens |
IC50 |
> |
100000.0 |
nM |
PMID[15857148] |
NPT139 |
Cell Line |
HT-29 |
Homo sapiens |
IC50 |
= |
100.0 |
nM |
PMID[15857148] |
NPT65 |
Cell Line |
HepG2 |
Homo sapiens |
IC50 |
= |
100.0 |
nM |
PMID[15857148] |
NPT2589 |
Cell Line |
Panel leukemia (Carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
100.0 |
nM |
PMID[17154522] |
NPT2589 |
Cell Line |
Panel leukemia (Carcinoma cell lines) |
Homo sapiens |
TGI |
= |
15848.93 |
nM |
PMID[17154522] |
NPT2589 |
Cell Line |
Panel leukemia (Carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
1584893192461.11 |
nM |
PMID[17154522] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
GI50 |
= |
251.19 |
nM |
PMID[17154522] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
TGI |
= |
15848.93 |
nM |
PMID[17154522] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
LC50 |
= |
251188.64 |
nM |
PMID[17154522] |
NPT116 |
Cell Line |
HL-60 |
Homo sapiens |
IC50 |
= |
11.2 |
ug.mL-1 |
PMID[17432904] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
GI50 |
= |
251.19 |
nM |
PMID[17559205] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
TGI |
= |
15848.93 |
nM |
PMID[17559205] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
LC50 |
= |
251188.64 |
nM |
PMID[17559205] |
NPT4720 |
Cell Line |
Leukemia cells |
Homo sapiens |
GI50 |
= |
100.0 |
nM |
PMID[19006285] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
GI50 |
= |
251.19 |
nM |
PMID[19006285] |
NPT3880 |
Cell Line |
Melanoma cells |
Homo sapiens |
GI50 |
= |
158.49 |
nM |
PMID[19006285] |
NPT4720 |
Cell Line |
Leukemia cells |
Homo sapiens |
TGI |
= |
15848.93 |
nM |
PMID[19006285] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
TGI |
= |
15848.93 |
nM |
PMID[19006285] |
NPT3880 |
Cell Line |
Melanoma cells |
Homo sapiens |
TGI |
= |
7943.28 |
nM |
PMID[19006285] |
NPT4720 |
Cell Line |
Leukemia cells |
Homo sapiens |
LC50 |
= |
630957.34 |
nM |
PMID[19006285] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
LC50 |
= |
251188.64 |
nM |
PMID[19006285] |
NPT3880 |
Cell Line |
Melanoma cells |
Homo sapiens |
LC50 |
= |
251188.64 |
nM |
PMID[19006285] |
NPT4720 |
Cell Line |
Leukemia cells |
Homo sapiens |
GI |
= |
0.1 |
uM |
PMID[19006285] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
GI |
= |
0.25 |
uM |
PMID[19006285] |
NPT3880 |
Cell Line |
Melanoma cells |
Homo sapiens |
GI |
= |
0.16 |
uM |
PMID[19006285] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
GI50 |
= |
200.0 |
nM |
PMID[20395150] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
TGI |
= |
15800.0 |
nM |
PMID[20395150] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
GI50 |
= |
250.0 |
nM |
PMID[20684599] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
TGI |
= |
15850.0 |
nM |
PMID[20684599] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
LC50 |
= |
251190.0 |
nM |
PMID[20684599] |
NPT858 |
Cell Line |
LNCaP |
Homo sapiens |
IC50 |
= |
2.9 |
nM |
PMID[20732809] |
NPT306 |
Cell Line |
PC-3 |
Homo sapiens |
IC50 |
= |
11.0 |
nM |
PMID[20732809] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
GI50 |
= |
250.0 |
nM |
PMID[22283430] |
NPT3877 |
Cell Line |
NSCLC |
Homo sapiens |
TGI |
= |
15850.0 |
nM |
PMID[22283430] |
NPT66 |
Individual Protein |
Acetylcholinesterase |
Electrophorus electricus |
Inhibition |
= |
10.9 |
% |
PMID[23062825] |
NPT1523 |
Cell Line |
NFF |
Homo sapiens |
IC50 |
= |
17.0 |
nM |
PMID[23215348] |
NPT306 |
Cell Line |
PC-3 |
Homo sapiens |
IC50 |
= |
15.0 |
nM |
PMID[23215348] |
NPT858 |
Cell Line |
LNCaP |
Homo sapiens |
IC50 |
= |
6.1 |
nM |
PMID[23215348] |
NPT165 |
Cell Line |
HeLa |
Homo sapiens |
IC50 |
= |
36.0 |
nM |
PMID[23215348] |
NPT81 |
Cell Line |
A549 |
Homo sapiens |
IC50 |
= |
20.0 |
nM |
PMID[23215348] |
NPT1523 |
Cell Line |
NFF |
Homo sapiens |
IC50 |
= |
16.9 |
nM |
PMID[23489291] |
NPT306 |
Cell Line |
PC-3 |
Homo sapiens |
IC50 |
= |
15.3 |
nM |
PMID[23489291] |
NPT165 |
Cell Line |
HeLa |
Homo sapiens |
IC50 |
= |
35.8 |
nM |
PMID[23489291] |
NPT2831 |
Cell Line |
P388/S |
Mus musculus |
Activity |
= |
96.0 |
% |
PMID[430477] |
NPT2831 |
Cell Line |
P388/S |
Mus musculus |
Activity |
= |
138.0 |
% |
PMID[430477] |
NPT2831 |
Cell Line |
P388/S |
Mus musculus |
Activity |
= |
83.0 |
% |
PMID[430477] |
NPT5929 |
Cell Line |
P388/VCR |
Mus musculus |
Activity |
= |
0.0 |
% |
PMID[430477] |
NPT5929 |
Cell Line |
P388/VCR |
Mus musculus |
Activity |
= |
1.2 |
% |
PMID[430477] |
NPT5929 |
Cell Line |
P388/VCR |
Mus musculus |
Activity |
= |
0.9 |
% |
PMID[430477] |
NPT5929 |
Cell Line |
P388/VCR |
Mus musculus |
Activity |
= |
0.6 |
% |
PMID[430477] |
NPT1161 |
Cell Line |
CHO |
Cricetulus griseus |
Activity |
= |
40.0 |
% |
PMID[430477] |
NPT1161 |
Cell Line |
CHO |
Cricetulus griseus |
Activity |
= |
10.0 |
% |
PMID[430477] |
NPT1034 |
Cell Line |
Lu1 |
Homo sapiens |
IC50 |
= |
480.0 |
nM |
PMID[26522953] |
NPT91 |
Cell Line |
KB |
Homo sapiens |
IC50 |
= |
20.0 |
nM |
PMID[26522953] |
NPT65 |
Cell Line |
HepG2 |
Homo sapiens |
IC50 |
= |
690.0 |
nM |
PMID[26522953] |
NPT83 |
Cell Line |
MCF7 |
Homo sapiens |
IC50 |
= |
510.0 |
nM |
PMID[26522953] |
NPT81 |
Cell Line |
A549 |
Homo sapiens |
IC50 |
= |
171.5 |
nM |
PMID[28038323] |
NPT82 |
Cell Line |
MDA-MB-231 |
Homo sapiens |
IC50 |
= |
116.6 |
nM |
PMID[28038323] |
NPT457 |
Cell Line |
BT-549 |
Homo sapiens |
IC50 |
= |
54.72 |
nM |
PMID[28038323] |
NPT306 |
Cell Line |
PC-3 |
Homo sapiens |
IC50 |
= |
27.6 |
nM |
PMID[28038323] |
NPT90 |
Cell Line |
DU-145 |
Homo sapiens |
IC50 |
= |
72.3 |
nM |
PMID[28038323] |
NPT612 |
Individual Protein |
Canalicular multispecific organic anion transporter 1 |
Homo sapiens |
IC50 |
> |
133000.0 |
nM |
PMID[23956101] |
NPT1249 |
Individual Protein |
Canalicular multispecific organic anion transporter 2 |
Homo sapiens |
IC50 |
> |
133000.0 |
nM |
PMID[23956101] |
NPT1028 |
Individual Protein |
Multidrug resistance-associated protein 4 |
Homo sapiens |
IC50 |
> |
133000.0 |
nM |
PMID[23956101] |
NPT90 |
Cell Line |
DU-145 |
Homo sapiens |
IC50 |
= |
71830.0 |
nM |
PMID[29174816] |
NPT306 |
Cell Line |
PC-3 |
Homo sapiens |
IC50 |
= |
28110.0 |
nM |
PMID[29174816] |
NPT25899 |
CELL-LINE |
Panel colon (Carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
100.0 |
nM |
PMID[12036377] |
NPT25900 |
CELL-LINE |
Panel CNS (Carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
125.89 |
nM |
PMID[12036377] |
NPT25901 |
CELL-LINE |
Panel melanoma (Carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
158.49 |
nM |
PMID[12036377] |
NPT25902 |
CELL-LINE |
Panel ovarian (Carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
316.23 |
nM |
PMID[12036377] |
NPT25903 |
CELL-LINE |
Panel renal (Carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
316.23 |
nM |
PMID[12036377] |
NPT25904 |
CELL-LINE |
Panel prostate (Carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
125.89 |
nM |
PMID[12036377] |
NPT25905 |
CELL-LINE |
Panel breast (Carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
316.23 |
nM |
PMID[12036377] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
199.53 |
nM |
PMID[12036377] |
NPT25899 |
CELL-LINE |
Panel colon (Carcinoma cell lines) |
Homo sapiens |
TGI |
= |
-5.4 |
n.a. |
PMID[12036377] |
NPT25900 |
CELL-LINE |
Panel CNS (Carcinoma cell lines) |
Homo sapiens |
TGI |
= |
-5.2 |
n.a. |
PMID[12036377] |
NPT25901 |
CELL-LINE |
Panel melanoma (Carcinoma cell lines) |
Homo sapiens |
TGI |
= |
-5.1 |
n.a. |
PMID[12036377] |
NPT25902 |
CELL-LINE |
Panel ovarian (Carcinoma cell lines) |
Homo sapiens |
TGI |
= |
-4.7 |
n.a. |
PMID[12036377] |
NPT25903 |
CELL-LINE |
Panel renal (Carcinoma cell lines) |
Homo sapiens |
TGI |
= |
-4.7 |
n.a. |
PMID[12036377] |
NPT25904 |
CELL-LINE |
Panel prostate (Carcinoma cell lines) |
Homo sapiens |
TGI |
= |
-5.2 |
n.a. |
PMID[12036377] |
NPT25905 |
CELL-LINE |
Panel breast (Carcinoma cell lines) |
Homo sapiens |
TGI |
= |
-5.1 |
n.a. |
PMID[12036377] |
NPT2 |
Others |
Unspecified |
|
TGI |
= |
-5.0 |
n.a. |
PMID[12036377] |
NPT25899 |
CELL-LINE |
Panel colon (Carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
-4.1 |
n.a. |
PMID[12036377] |
NPT25900 |
CELL-LINE |
Panel CNS (Carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
-3.7 |
n.a. |
PMID[12036377] |
NPT25901 |
CELL-LINE |
Panel melanoma (Carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
-3.6 |
n.a. |
PMID[12036377] |
NPT25902 |
CELL-LINE |
Panel ovarian (Carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
-3.5 |
n.a. |
PMID[12036377] |
NPT25903 |
CELL-LINE |
Panel renal (Carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
-3.6 |
n.a. |
PMID[12036377] |
NPT25904 |
CELL-LINE |
Panel prostate (Carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
-3.5 |
n.a. |
PMID[12036377] |
NPT25905 |
CELL-LINE |
Panel breast (Carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
-3.5 |
n.a. |
PMID[12036377] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
-3.6 |
n.a. |
PMID[12036377] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
IC50 |
< |
0.1 |
nM |
PMID[15857148] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
IC50 |
= |
1.0 |
nM |
PMID[15857148] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
IC50 |
= |
100.0 |
nM |
PMID[15857148] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
IC50 |
= |
10.0 |
nM |
PMID[15857148] |
NPT25899 |
CELL-LINE |
Panel colon (Carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
100.0 |
nM |
PMID[17154522] |
NPT25899 |
CELL-LINE |
Panel colon (Carcinoma cell lines) |
Homo sapiens |
TGI |
= |
3981.07 |
nM |
PMID[17154522] |
NPT25899 |
CELL-LINE |
Panel colon (Carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
79432.82 |
nM |
PMID[17154522] |
NPT25900 |
CELL-LINE |
Panel CNS (Carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
125.89 |
nM |
PMID[17154522] |
NPT25900 |
CELL-LINE |
Panel CNS (Carcinoma cell lines) |
Homo sapiens |
TGI |
= |
6309.57 |
nM |
PMID[17154522] |
NPT25900 |
CELL-LINE |
Panel CNS (Carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
199526.23 |
nM |
PMID[17154522] |
NPT25901 |
CELL-LINE |
Panel melanoma (Carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
158.49 |
nM |
PMID[17154522] |
NPT25901 |
CELL-LINE |
Panel melanoma (Carcinoma cell lines) |
Homo sapiens |
TGI |
= |
7943.28 |
nM |
PMID[17154522] |
NPT25901 |
CELL-LINE |
Panel melanoma (Carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
251188.64 |
nM |
PMID[17154522] |
NPT25902 |
CELL-LINE |
Panel ovarian (Carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
316.23 |
nM |
PMID[17154522] |
NPT25902 |
CELL-LINE |
Panel ovarian (Carcinoma cell lines) |
Homo sapiens |
TGI |
= |
19952.62 |
nM |
PMID[17154522] |
NPT25902 |
CELL-LINE |
Panel ovarian (Carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
251188.64 |
nM |
PMID[17154522] |
NPT25903 |
CELL-LINE |
Panel renal (Carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
316.23 |
nM |
PMID[17154522] |
NPT25903 |
CELL-LINE |
Panel renal (Carcinoma cell lines) |
Homo sapiens |
TGI |
= |
19952.62 |
nM |
PMID[17154522] |
NPT25903 |
CELL-LINE |
Panel renal (Carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
251188.64 |
nM |
PMID[17154522] |
NPT25904 |
CELL-LINE |
Panel prostate (Carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
125.89 |
nM |
PMID[17154522] |
NPT25904 |
CELL-LINE |
Panel prostate (Carcinoma cell lines) |
Homo sapiens |
TGI |
= |
6309.57 |
nM |
PMID[17154522] |
NPT25905 |
CELL-LINE |
Panel breast (Carcinoma cell lines) |
Homo sapiens |
GI50 |
= |
316.23 |
nM |
PMID[17154522] |
NPT25905 |
CELL-LINE |
Panel breast (Carcinoma cell lines) |
Homo sapiens |
TGI |
= |
7943.28 |
nM |
PMID[17154522] |
NPT25905 |
CELL-LINE |
Panel breast (Carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
316227.77 |
nM |
PMID[17154522] |
NPT25904 |
CELL-LINE |
Panel prostate (Carcinoma cell lines) |
Homo sapiens |
LC50 |
= |
316227.77 |
nM |
PMID[17154522] |
NPT27 |
Others |
Unspecified |
|
IC50 |
= |
26.7 |
ug.mL-1 |
PMID[17432904] |
NPT27 |
Others |
Unspecified |
|
IC50 |
= |
28.4 |
ug.mL-1 |
PMID[17432904] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
100.0 |
nM |
PMID[17559205] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
15848.93 |
nM |
PMID[17559205] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
1584893192461.11 |
nM |
PMID[17559205] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
3981.07 |
nM |
PMID[17559205] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
79432.82 |
nM |
PMID[17559205] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
125.89 |
nM |
PMID[17559205] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
6309.57 |
nM |
PMID[17559205] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
199526.23 |
nM |
PMID[17559205] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
158.49 |
nM |
PMID[17559205] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
7943.28 |
nM |
PMID[17559205] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
251188.64 |
nM |
PMID[17559205] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
316.23 |
nM |
PMID[17559205] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
19952.62 |
nM |
PMID[17559205] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
316227.77 |
nM |
PMID[17559205] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
100.0 |
nM |
PMID[19006285] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
125.89 |
nM |
PMID[19006285] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
316.23 |
nM |
PMID[19006285] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
3981.07 |
nM |
PMID[19006285] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
6309.57 |
nM |
PMID[19006285] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
19952.62 |
nM |
PMID[19006285] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
7943.28 |
nM |
PMID[19006285] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
79432.82 |
nM |
PMID[19006285] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
199526.23 |
nM |
PMID[19006285] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
316227.77 |
nM |
PMID[19006285] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
251188.64 |
nM |
PMID[19006285] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI |
= |
0.1 |
uM |
PMID[19006285] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI |
= |
0.13 |
uM |
PMID[19006285] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI |
= |
0.32 |
uM |
PMID[19006285] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
100.0 |
nM |
PMID[18598018] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
15848.93 |
nM |
PMID[18598018] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
630957.34 |
nM |
PMID[18598018] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
251.19 |
nM |
PMID[18598018] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
251188.64 |
nM |
PMID[18598018] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
3981.07 |
nM |
PMID[18598018] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
79432.82 |
nM |
PMID[18598018] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
125.89 |
nM |
PMID[18598018] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
6309.57 |
nM |
PMID[18598018] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
199526.23 |
nM |
PMID[18598018] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
158.49 |
nM |
PMID[18598018] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
7943.28 |
nM |
PMID[18598018] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
316.23 |
nM |
PMID[18598018] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
19952.62 |
nM |
PMID[18598018] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
316227.77 |
nM |
PMID[18598018] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
100.0 |
nM |
PMID[20395150] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
200.0 |
nM |
PMID[20395150] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
300.0 |
nM |
PMID[20395150] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
15800.0 |
nM |
PMID[20395150] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
4000.0 |
nM |
PMID[20395150] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
6300.0 |
nM |
PMID[20395150] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
7900.0 |
nM |
PMID[20395150] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
19900.0 |
nM |
PMID[20395150] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
100.0 |
nM |
PMID[20684599] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
15850.0 |
nM |
PMID[20684599] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
630960.0 |
nM |
PMID[20684599] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
3980.0 |
nM |
PMID[20684599] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
79430.0 |
nM |
PMID[20684599] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
130.0 |
nM |
PMID[20684599] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
6310.0 |
nM |
PMID[20684599] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
199530.0 |
nM |
PMID[20684599] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
160.0 |
nM |
PMID[20684599] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
7940.0 |
nM |
PMID[20684599] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
251190.0 |
nM |
PMID[20684599] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
320.0 |
nM |
PMID[20684599] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
19950.0 |
nM |
PMID[20684599] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
316230.0 |
nM |
PMID[20684599] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
100.0 |
nM |
PMID[19734910] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
1000.0 |
nM |
PMID[19734910] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
199.53 |
nM |
PMID[19734910] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
3162.28 |
nM |
PMID[19734910] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
1584.89 |
nM |
PMID[19734910] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
50.12 |
nM |
PMID[19734910] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
320.0 |
nM |
PMID[22283430] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
130.0 |
nM |
PMID[22283430] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
160.0 |
nM |
PMID[22283430] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
100.0 |
nM |
PMID[22283430] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
15850.0 |
nM |
PMID[22283430] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
3980.0 |
nM |
PMID[22283430] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
6310.0 |
nM |
PMID[22283430] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
7940.0 |
nM |
PMID[22283430] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
19950.0 |
nM |
PMID[22283430] |
NPT67 |
Individual Protein |
Cholinesterase |
Equus caballus |
Inhibition |
= |
2.81 |
% |
PMID[23062825] |
NPT27 |
Others |
Unspecified |
|
IC50 |
= |
31.0 |
nM |
PMID[23215348] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
51.0 |
% |
PMID[430477] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
0.0 |
% |
PMID[430477] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
76.0 |
% |
PMID[430477] |
NPT32 |
Organism |
Mus musculus |
Mus musculus |
LD50 |
= |
2.1 |
mg.kg-1 |
PMID[430477] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
Activity |
= |
1.5 |
day |
PMID[430477] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
Activity |
= |
15.0 |
% |
PMID[430477] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
100.0 |
nM |
PMID[24747749] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
15850.0 |
nM |
PMID[24747749] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
630960.0 |
nM |
PMID[24747749] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
250.0 |
nM |
PMID[24747749] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
251190.0 |
nM |
PMID[24747749] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
3980.0 |
nM |
PMID[24747749] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
79430.0 |
nM |
PMID[24747749] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
160.0 |
nM |
PMID[24747749] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
7940.0 |
nM |
PMID[24747749] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
320.0 |
nM |
PMID[24747749] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
19950.0 |
nM |
PMID[24747749] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
316230.0 |
nM |
PMID[24747749] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
GI50 |
= |
130.0 |
nM |
PMID[24747749] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
6310.0 |
nM |
PMID[24747749] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
LC50 |
= |
199530.0 |
nM |
PMID[24747749] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
75.0 |
% |
PMID[412968] |
NPT32 |
Organism |
Mus musculus |
Mus musculus |
LD50 |
= |
2.1 |
mg.kg-1 |
PMID[412968] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
TGI |
= |
77.0 |
% |
PMID[412968] |
NPT29 |
Organism |
Rattus norvegicus |
Rattus norvegicus |
LD50 |
= |
1.0 |
mg.kg-1 |
PMID[412968] |
NPT713 |
Individual Protein |
Bile salt export pump |
Homo sapiens |
IC50 |
> |
133000.0 |
nM |
PMID[23956101] |
NPT19 |
Organism |
Escherichia coli |
Escherichia coli |
Inhibition |
= |
2.79 |
% |
DOI[10.6019/CHEMBL4296181] |
NPT18 |
Organism |
Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
= |
1.62 |
% |
DOI[10.6019/CHEMBL4296181] |
NPT20 |
Organism |
Candida albicans |
Candida albicans |
Inhibition |
= |
-0.39 |
% |
DOI[10.6019/CHEMBL4296181] |
NPT85 |
Organism |
Filobasidiella neoformans |
Cryptococcus neoformans |
Inhibition |
= |
-1.83 |
% |
DOI[10.6019/CHEMBL4296181] |
NPT2922 |
Organism |
Staphylococcus aureus subsp. aureus |
Staphylococcus aureus subsp. aureus |
Inhibition |
= |
-14.43 |
% |
DOI[10.6019/CHEMBL4296181] |
NPT173 |
Organism |
Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
= |
1.69 |
% |
DOI[10.6019/CHEMBL4296181] |
NPT747 |
Organism |
Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
= |
-6.71 |
% |
DOI[10.6019/CHEMBL4296181] |